SA113350005B1 - عملية جديدة لتصنيع ( e2)-3-(3، 4-داي ميثوكسي فينيل) بروب-2-إنينيتريل، وتطبيقها في تصنيع إيڤابرادين وأملاحه مضافة مع حمض مقبول صيدلانيا - Google Patents

عملية جديدة لتصنيع ( e2)-3-(3، 4-داي ميثوكسي فينيل) بروب-2-إنينيتريل، وتطبيقها في تصنيع إيڤابرادين وأملاحه مضافة مع حمض مقبول صيدلانيا

Info

Publication number
SA113350005B1
SA113350005B1 SA113350005A SA113350005A SA113350005B1 SA 113350005 B1 SA113350005 B1 SA 113350005B1 SA 113350005 A SA113350005 A SA 113350005A SA 113350005 A SA113350005 A SA 113350005A SA 113350005 B1 SA113350005 B1 SA 113350005B1
Authority
SA
Saudi Arabia
Prior art keywords
synthesis
dimethoxyphenyl
ivabradine
enenitrile
prop
Prior art date
Application number
SA113350005A
Other languages
English (en)
Inventor
لورينزو غونزاليز خوسيه
سانشيز فريديريك
إيزابيل جارسيا اراندا ماريا
ديل بيلار كارانزا ماريا
Original Assignee
لي لابوراتوريز سيرفير
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by لي لابوراتوريز سيرفير filed Critical لي لابوراتوريز سيرفير
Publication of SA113350005B1 publication Critical patent/SA113350005B1/ar

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/32—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/44—Palladium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/34—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring with cyano groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by unsaturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)

Abstract

يتعلق الاختراع الحالي بعملية (P1) لتخليق (2E)-3-(3، 4-داي ميثوكسي فينيل)بروب-2-ين نيتريل (I): تشتمل على تعريض 4-برومو-1، 2-داي ميثوكسي بنزين (II) لتفاعل إقران بأكريلو نيتريل في وجود محفز من البالاديوم، ومركب ترابطي، ومادة قاعدية وعامل لنقل الطور في مذيب عضوي للحصول على (I). علاوة على ذلك تشتمل العملية المذكورة على تعريض 4-برومو-1، 2-داي ميثوكسي بنزين له الصيغة (II) لتفاعل إقران بأكريلو نيتريل في وجود محفز من البالاديوم، ومركب ترابطي، ومادة قاعدية وعامل لنقل الطور في مذيب عضوي للحصول على (I). وتطبيقها في تخليق إيڤابرادين، وأملاح الإضافة منه مع حمض مقبول صيدلانياً.
SA113350005A 2012-11-08 2013-11-06 عملية جديدة لتصنيع ( e2)-3-(3، 4-داي ميثوكسي فينيل) بروب-2-إنينيتريل، وتطبيقها في تصنيع إيڤابرادين وأملاحه مضافة مع حمض مقبول صيدلانيا SA113350005B1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1260576A FR2997696B1 (fr) 2012-11-08 2012-11-08 Nouveau procede de synthese du (2e)-3-(3,4-dimethoxyphenyl)prop-2-enenitrile, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Publications (1)

Publication Number Publication Date
SA113350005B1 true SA113350005B1 (ar) 2015-12-06

Family

ID=47598957

Family Applications (1)

Application Number Title Priority Date Filing Date
SA113350005A SA113350005B1 (ar) 2012-11-08 2013-11-06 عملية جديدة لتصنيع ( e2)-3-(3، 4-داي ميثوكسي فينيل) بروب-2-إنينيتريل، وتطبيقها في تصنيع إيڤابرادين وأملاحه مضافة مع حمض مقبول صيدلانيا

Country Status (36)

Country Link
US (1) US8779122B2 (ar)
EP (1) EP2730562B1 (ar)
JP (2) JP6058519B2 (ar)
KR (1) KR20140059731A (ar)
CN (1) CN103804225B (ar)
AR (1) AR093373A1 (ar)
AU (1) AU2013245452C1 (ar)
BR (1) BR102013028259A2 (ar)
CA (1) CA2831289C (ar)
CY (1) CY1116253T1 (ar)
DK (1) DK2730562T3 (ar)
EA (1) EA027080B1 (ar)
ES (1) ES2539618T3 (ar)
FR (1) FR2997696B1 (ar)
GE (1) GEP20156308B (ar)
HK (2) HK1193408A1 (ar)
HR (1) HRP20150570T1 (ar)
HU (1) HUE026525T2 (ar)
JO (1) JO3189B1 (ar)
MA (1) MA35147B1 (ar)
MD (1) MD4392C1 (ar)
ME (1) ME02120B (ar)
MX (1) MX355590B (ar)
MY (1) MY159701A (ar)
NZ (1) NZ616768A (ar)
PL (1) PL2730562T3 (ar)
PT (1) PT2730562E (ar)
RS (1) RS53993B1 (ar)
SA (1) SA113350005B1 (ar)
SG (1) SG2013077235A (ar)
SI (1) SI2730562T1 (ar)
TW (1) TWI488833B (ar)
UA (1) UA118008C2 (ar)
UY (1) UY35108A (ar)
WO (1) WO2014072640A1 (ar)
ZA (1) ZA201308001B (ar)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3101010A1 (en) 2015-06-03 2016-12-07 Urquima S.A. New method for the preparation of highly pure ivabradine base and salts thereof
CN105541605A (zh) * 2016-02-04 2016-05-04 扬州大学 一种轴手性联萘配体前体(s)-2,2’-二羧酸-1,1’-联萘的合成方法
IL272964B2 (en) 2017-08-31 2024-02-01 Daiichi Sankyo Co Ltd Production method for antibody-drug conjugates

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5310598B2 (ar) * 1972-01-28 1978-04-14
JPH0753692B2 (ja) * 1990-10-30 1995-06-07 工業技術院長 芳香族カルボン酸エステル類の製造方法
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
DE4333711A1 (de) * 1993-10-02 1995-04-06 Hoechst Ag 2,4,5-Trihalogenzimtsäurenitrile und Verfahren zu ihrer Herstellung
DE10159270A1 (de) * 2001-12-03 2003-06-12 Bayer Ag Verfahren zur Arylierung von Olefinen
WO2005123662A1 (en) * 2004-06-18 2005-12-29 Janssen Pharmaceutica N.V. Modified heck reaction
CN101407474B (zh) * 2008-11-18 2011-12-14 东华大学 一种2-溴-4,5-二甲氧基苯丙腈的制备方法
US8863583B2 (en) 2010-05-06 2014-10-21 Shimadzu Corporation Material testing system
HUP1000245A2 (en) * 2010-05-07 2011-11-28 Richter Gedeon Nyrt Industrial process for the production ivabradin salts
CN102464595B (zh) * 2010-11-17 2015-02-25 山东新时代药业有限公司 一种伊伐布雷定中间体的合成方法

Also Published As

Publication number Publication date
US8779122B2 (en) 2014-07-15
ME02120B (me) 2015-10-20
MX2013012858A (es) 2014-08-07
FR2997696B1 (fr) 2014-12-05
MX355590B (es) 2018-04-24
AU2013245452B2 (en) 2017-02-16
US20140128598A1 (en) 2014-05-08
CN103804225A (zh) 2014-05-21
CA2831289A1 (en) 2014-05-08
KR20140059731A (ko) 2014-05-16
MA35147B1 (fr) 2014-06-02
FR2997696A1 (fr) 2014-05-09
EP2730562A1 (fr) 2014-05-14
CN103804225B (zh) 2016-02-17
EA201301136A3 (ru) 2014-07-30
JP6058519B2 (ja) 2017-01-11
NZ616768A (en) 2015-02-27
ZA201308001B (en) 2014-07-30
UY35108A (es) 2014-05-30
JP2016047837A (ja) 2016-04-07
MY159701A (en) 2017-01-13
HUE026525T2 (en) 2016-06-28
UA118008C2 (uk) 2018-11-12
JO3189B1 (ar) 2018-03-08
AU2013245452C1 (en) 2017-06-22
HK1193408A1 (en) 2014-09-19
RS53993B1 (en) 2015-10-30
HK1198159A1 (zh) 2015-03-13
TWI488833B (zh) 2015-06-21
EA027080B1 (ru) 2017-06-30
EA201301136A2 (ru) 2014-05-30
SI2730562T1 (sl) 2015-07-31
PT2730562E (pt) 2015-05-20
GEP20156308B (en) 2015-06-25
DK2730562T3 (en) 2015-06-29
JP2014114275A (ja) 2014-06-26
HRP20150570T1 (en) 2015-07-03
SG2013077235A (en) 2014-06-27
TW201418197A (zh) 2014-05-16
PL2730562T3 (pl) 2015-08-31
CA2831289C (en) 2016-02-09
AU2013245452A1 (en) 2014-05-22
MD4392B1 (ro) 2016-01-31
AR093373A1 (es) 2015-06-03
MD4392C1 (ro) 2016-08-31
EP2730562B1 (fr) 2015-03-25
ES2539618T3 (es) 2015-07-02
BR102013028259A2 (pt) 2014-10-07
WO2014072640A1 (fr) 2014-05-15
CY1116253T1 (el) 2017-02-08
MD20130082A2 (en) 2014-05-31

Similar Documents

Publication Publication Date Title
GEP20125512B (en) Process for synthesis of agomelatin
MX2009009355A (es) Compuesto de bencimidazol y uso farmaceutico del mismo.
MY145992A (en) New process for the resolution of enantiomers of (3,4-dimethoxy-bicyclo[4.2.0]octa-1,3-5-trien-7-yl)nitrile and application in the synthesis of ivabradine
GEP20125407B (en) New process for the synthesis of 7,8-dimethoxy-1,3-dihydro-2h-3- benzazepin-2-one, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
SA113350005B1 (ar) عملية جديدة لتصنيع ( e2)-3-(3، 4-داي ميثوكسي فينيل) بروب-2-إنينيتريل، وتطبيقها في تصنيع إيڤابرادين وأملاحه مضافة مع حمض مقبول صيدلانيا
ME00986B (me) Novi postupak sinteze ivabradina i njegovih adicionih soli sa farmaceutski prihvatljivom kiselinom
NZ716462A (en) Optically active pde10 inhibitor
WO2014072998A9 (en) An improved process for preparation of agomelatine
HU1000668D0 (en) New palladium catalysts, process for their preparation and use thereof
GEP20125460B (en) New process for the synthesis of ivabradine and its pharmaceutically acceptable acid addition salts
WO2015022702A3 (en) Process for preparation of 4,5-dimethoxybenzene derivatives and use in the synthesis of ivabradine and salts thereof
MD4443C1 (ro) Procedeu de sinteză a 3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7-carbonitrilului şi aplicarea lui în sinteza ivabradinei şi a sărurilor sale de adiţie cu un acid acceptabil farmaceutic
SA113350048B1 (ar) عملية جديدة لتصنيع 3-(2-برومو-4، 5- داي ميثوكسي فينيل) بروبان نيتريل، واستخدامها في تصنيع افابرادين وإضافة أملاح منه مع حمض مقبول صيدلانياً
RU2013110311A (ru) Синтез соединений тиазолидиндиона
MX2015013805A (es) Proceso para preparar sulfiminas y su conversion in situ en n-(2-amino-benzoil)-sulfiminas.
WO2011048612A3 (en) Process for preparation of propargylated aminoindans or pharmaceutically acceptable salts thereof
MD20130071A2 (en) New process for the synthesis of 3-(2-bromo-4,5-dimethoxyphenyl)propanenitrile and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
RS54652B1 (en) NEW PROCEDURE FOR THE SYNTHESIS OF IVABRADINE AND ITS PHARMACEUTICALALLY ACCEPTABLE ACID ADDITIVE SALTS
IN2013DE03349A (ar)
TH159831A (th) วิธีการสำหรับการผลิตเมทธิลฟอร์เมตโดยการเกิดปฏิกิริยาของเมทธานอลกับคาร์บอน มอนนอกไซด์ในการมีอยู่ของระบบคะตะลิสต์ ซึ่งประกอบด้วยอัลคาไลฟอร์เมต และอัลคาไลแอลกฮอเลต